UK markets closed

Aileron Therapeutics, Inc. (ALRN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.0000-0.0600 (-1.19%)
As of 02:07PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
3,991
3,991
17,967
17,008
11,166
Selling general and administrative
11,357
11,357
9,680
9,597
9,330
Total operating expenses
15,348
15,348
27,647
26,605
20,496
Operating income or loss
-15,348
-15,348
-27,647
-26,605
-20,496
Total other income/expenses net
-728
-728
318
441
-700
Income before tax
-15,676
-15,676
-27,329
-26,164
-21,196
Income from continuing operations
-15,676
-15,676
-27,329
-26,164
-21,196
Net income
-15,732
-15,732
-27,329
-26,164
-21,157
Net income available to common shareholders
-15,732
-15,732
-27,329
-26,164
-21,157
Basic EPS
-2.85
-3.42
-6.02
-5.89
-12.20
Diluted EPS
-2.85
-3.42
-6.02
-5.89
-12.20
Basic average shares
4,541
4,599
4,539
4,440
1,743
Diluted average shares
4,541
4,599
4,539
4,440
1,743